Search Results | Blood | American Society of Hematology

1-20 of 88

Sort by

Sort Order Select

Journal Articles

Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis

Nosha Farhadfar, Zeina Al-Mansour, Tao Wang, Karen Chen, Joseph Pidala, Margaret L. MacMillan, Carrie Lynn Kitko, Stephen R. Spellman, John R. Wingard, Stephanie J. Lee

Blood (2022) 140 (Supplement 1): 5108–5109.

DOI: https://doi.org/10.1182/blood-2022-163537

Published: 2022

Journal Articles

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

Blood (2022) 140 (Supplement 1): 8019–8021.

DOI: https://doi.org/10.1182/blood-2022-167411

Published: 2022

Journal Articles

Distress, Health-Related Quality of Life (HQOL) and Confidence in Survivorship Information (CSI) in Older (≥60 Years) Hematopoietic Cell Transplant (HCT) Patients

Zeina Al-Mansour, Sanghee Hong, Nosha Farhadfar, Jing Zhao, Ji-Hyun Lee, Bronwen E. Shaw, Steven Devine, Jean C. Yi, Jaime M. Preussler, K. Scott Baker, Karen Syrjala, Navneet S. Majhail, John R. Wingard

Blood (2021) 138 (Supplement 1): 426.

DOI: https://doi.org/10.1182/blood-2021-151037

Published: 2021

Journal Articles

Cancer and Treatment Distress (CTXD) and Confidence in Survivorship Information (CSI) Trends in Older (≥60 Years) Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Survivors

Sanghee Hong, Jing Zhao, Ji-Hyun Lee, Nosha Farhadfar, Jean C. Yi, Jaime M. Preussler, K. Scott Baker, Bronwen E. Shaw, Steven Devine, Karen Syrjala, John R. Wingard, Navneet S. Majhail, Zeina Al-Mansour

Blood (2021) 138 (Supplement 1): 4123.

DOI: https://doi.org/10.1182/blood-2021-145428

Published: 2021

Journal Articles

Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors

Nosha Farhadfar, Michael Weaver, Zeina Al-Mansour, Jean C. Yi, Heather S. L. Jim, Alison W. Loren, Navneet S. Majhail, Victoria Whalen, John R. Wingard, Debra Lynch Kelly, Karen Syrjala

Blood (2021) 138 (Supplement 1): 3932.

DOI: https://doi.org/10.1182/blood-2021-147968

Published: 2021

Journal Articles

The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Rdsafe and BMT CTN 0201

Nosha Farhadfar, Stephanie Bo-Subait, Kwang Woo Ahn, Brent R. Logan, Heather E. Stefanski, Jack W. Hsu, Sandhya R. Panch, Dennis L. Confer, Claudio Anasetti, Michael A. Pulsipher, Bronwen E. Shaw, John R. Wingard, Galen E. Switzer

Blood (2021) 138 (Supplement 1): 1772.

DOI: https://doi.org/10.1182/blood-2021-151034

Published: 2021

Journal Articles

Impact of Cryopreservation of Donor Grafts on Outcomes of Allogeneic Hematopoietic Cell Transplant (HCT)

Jack W. Hsu, MD, Nosha Farhadfar, MD, Hemant S. Murthy, MD, Brent Logan, PhD, Stephanie Bo-Subait, MPH, Noelle V. Frey, MD, Steven C. Goldstein, MD, Mary M. Horowitz, MD MS, Hillard M Lazarus, MD, Joshua Schwanke, Nirali N. Shah, MD, Stephen R. Spellman, MS, Galen E. Switzer, PhD, Steven M Devine, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, John R. Wingard, MD

Blood (2020) 136 (Supplement 1): 33–34.

DOI: https://doi.org/10.1182/blood-2020-136778

Published: 2020

Journal Articles

Impact of Severity of Acute Graft-Versus-Host Disease on Healthcare Resource Utilization, Cost and Outcomes

Nosha Farhadfar, MD, Helen L Leather, Shu Wang, Nathan Burton, Vivian Irizarry Gatell, MD, Robbin Itzler, Ramzi G Salloum, John R. Wingard, MD

Blood (2020) 136 (Supplement 1): 37–38.

DOI: https://doi.org/10.1182/blood-2020-137824

Published: 2020

Journal Articles

Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) Survivors

Nosha Farhadfar, MD, Debra Lynch Kelly, PhD, Lacey E. Mead, BS, Shalini Nair, Randy A. Brown, MD, John W. Hiemenz, MD, Jack W. Hsu, MD, Hemant S. Murthy, MD, W. Stratford May, MD PhD, John R. Wingard, MD, Wendy J Dahl, PhD

Blood (2019) 134 (Supplement_1): 4565.

DOI: https://doi.org/10.1182/blood-2019-127648

Published: 2019

Journal Articles

Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

Nosha Farhadfar, MD, Ajoy L. Dias, MD, Tao Wang, PhD, Caitrin Fretham, Hemant S. Murthy, MD, Brent R. Logan, Shin Mineishi, MD, Bipin N. Savani, MD, Edward A. Stadtmauer, MD FACP, Saurabh Chhabra, MD, John R. Wingard, MD, Siddhartha Ganguly, MD, Marcelo C. Pasquini, MDMS

Blood (2019) 134 (Supplement_1): 3256.

DOI: https://doi.org/10.1182/blood-2019-125761

Published: 2019

Journal Articles

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Blood (2018) 132 (Supplement 1): 1015.

DOI: https://doi.org/10.1182/blood-2018-99-110814

Published: 2018

Journal Articles

Microbiota Phylogenic Analysis Revealed Decreased Abundance of Faecalibacterium Prausnitzii , an Anti-Inflammatory Commensal Bacterium, in Patients with Chronic Graft-Versus-Host Disease

Nosha Farhadfar, MD, Raad Z. Gharaibeh, PhD, John R. Wingard, MD, Debra Lyon, PhD RN, FAAN, Christian Jobin, PhD, Gary P Wang, MD PhD, Michael Raymond Weaver, BA, Hemant S. Murthy, MD, Debra Lynch Kelly, PhD RN, OCN, CNE

Blood (2018) 132 (Supplement 1): 2119.

DOI: https://doi.org/10.1182/blood-2018-99-113658

Published: 2018

Journal Articles

Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield

Nosha Farhadfar, MD, Jack W. Hsu, MD, Brent R. Logan, PhD, Jennifer A. Sees, MPH, Pintip Chitphakdithai, PhD, Dennis L. Confer, MD, Michael A. Pulsipher, MD, Nirali N. Shah, MD, Galen E. Switzer, PhD, Bronwen E. Shaw, MD PhD, John R. Wingard, MD

Blood (2018) 132 (Supplement 1): 193.

DOI: https://doi.org/10.1182/blood-2018-193

Published: 2018

Journal Articles

The microbiome: more than a gut reaction

John R. Wingard

Blood (2018) 131 (26): 2874–2875.

DOI: https://doi.org/10.1182/blood-2018-05-847509

Published: 2018

Journal Articles

A Genomic Signature Predicting Venetoclax Treatment Response in Acute Myeloid Leukemia (AML) Identified By Protein Network Mapping and Validated By Ex Vivo Ddrug Sensitivity Testing

Blood (2017) 130 (Supplement 1): 2707.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2707.2707

Published: 2017

Journal Articles

Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients

Maxim Norkin, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, Ruta Brazauskas, PhD, Heather R. Millard, MPH, Mary E. Flowers, MD, Minoo Battiwalla, MD, Bipin N. Savani, MD, Marcie L. Riches, MDMS, Juan Gea-Banacloche, MD, John R. Wingard, MD

Blood (2017) 130 (Supplement 1): 334.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.334.334

Published: 2017

Journal Articles

Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant

Blood (2017) 130 (Supplement 1): 335.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.335.335

Published: 2017

Journal Articles

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Edmund K. Waller, MD, Brent R. Logan, PhD, Mingwei Fei, MS, Alan Howard, PhD, John R. Wingard, MD, Claudio Anasetti, MD, Cynthia R. Giver, PhD

Blood (2017) 130 (Supplement 1): 1972.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1972.1972

Published: 2017

Journal Articles

Digital Drug Screening and Computational Modeling Identifies Treatment Opportunities Despite Lack of Directly Actionable Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Blood (2017) 130 (Supplement 1): 3910.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3910.3910

Published: 2017

Journal Articles

Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center

Forat Lutfi, MD, William Paul Skelton, IV, MD, Emma Rosenau, Nosha Farhadfar, MD, Hemant S. Murthy, MD, W. Stratford May, MD PhD, John W. Hiemenz, MD, Christopher R. Cogle, MD, Randy A. Brown, MD, Sarah Wheeler, RPH, John R. Wingard, MD, Maxim Norkin, MD

Blood (2017) 130 (Supplement 1): 4529.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4529.4529

Published: 2017

NARROW

Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

Distress, Health-Related Quality of Life (HQOL) and Confidence in Survivorship Information (CSI) in Older (≥60 Years) Hematopoietic Cell Transplant (HCT) Patients

Cancer and Treatment Distress (CTXD) and Confidence in Survivorship Information (CSI) Trends in Older (≥60 Years) Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Survivors

Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors

The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Rdsafe and BMT CTN 0201

Impact of Cryopreservation of Donor Grafts on Outcomes of Allogeneic Hematopoietic Cell Transplant (HCT)

Impact of Severity of Acute Graft-Versus-Host Disease on Healthcare Resource Utilization, Cost and Outcomes

Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) Survivors

Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Microbiota Phylogenic Analysis Revealed Decreased Abundance of Faecalibacterium Prausnitzii , an Anti-Inflammatory Commensal Bacterium, in Patients with Chronic Graft-Versus-Host Disease

Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield

The microbiome: more than a gut reaction

A Genomic Signature Predicting Venetoclax Treatment Response in Acute Myeloid Leukemia (AML) Identified By Protein Network Mapping and Validated By Ex Vivo Ddrug Sensitivity Testing

Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients

Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Digital Drug Screening and Computational Modeling Identifies Treatment Opportunities Despite Lack of Directly Actionable Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only